MAPT and Alzheimer disease: Therefore, the current AD treatment methods based on tau protein are mainly divided into non-immunotherapeutic approaches based on stabilizing microtubules, inhibition of tau protein phosphorylation and aggregation, or inhibition of pathological tau diffusion, and active and passive immunotherapy approaches, including vaccination and monoclonal antibodies.